157 related articles for article (PubMed ID: 6345754)
1. Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.
Kerchner GA; Geary LE
J Pharmacol Exp Ther; 1983 Jul; 226(1):33-8. PubMed ID: 6345754
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
[TBL] [Abstract][Full Text] [Related]
3. Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
Uchiyama T; Kotani A; Kishida T; Tatsumi H; Okamoto A; Fujita T; Murakami M; Muranishi S; Yamamoto A
J Pharm Sci; 1998 Apr; 87(4):448-52. PubMed ID: 9548897
[TBL] [Abstract][Full Text] [Related]
4. Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.
Uchiyama T; Kotani A; Tatsumi H; Kishida T; Okamoto A; Okada N; Murakami M; Fujita T; Fujiwara Y; Kiso Y; Muranishi S; Yamamoto A
Pharm Res; 2000 Dec; 17(12):1461-7. PubMed ID: 11303954
[TBL] [Abstract][Full Text] [Related]
5. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
Weinberger SB; Martinez JL
J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
[TBL] [Abstract][Full Text] [Related]
6. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
Cohen ML; Geary LE; Wiley KS
J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
[TBL] [Abstract][Full Text] [Related]
7. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
8. Opiate-like peptides. Part VIII. Methylamides and dimethylamides of [D-Leu5]-enkephalin and [D-Ala2, D-Leu5]-enkephalin. Synthesis and analgesic activity.
Rolka K; Kolasa K; Kleinrok Z; Kupryszewski G
Pol J Pharmacol Pharm; 1986; 38(4):391-402. PubMed ID: 3534824
[TBL] [Abstract][Full Text] [Related]
9. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).
Zlokovic BV; Begley DJ; Chain-Eliash DG
Brain Res; 1985 Jun; 336(1):125-32. PubMed ID: 3891014
[TBL] [Abstract][Full Text] [Related]
11. Characterization of enkephalin degradation in rat plasma.
Weinberger SB; Zafuto CE; Walker RC; Martinez JL
NIDA Res Monogr; 1986; 75():263-6. PubMed ID: 3123942
[TBL] [Abstract][Full Text] [Related]
12. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
13. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of aminopeptidases from Aplysia californica.
Bawab W; Querido E; Crine P; DesGroseillers L
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
[TBL] [Abstract][Full Text] [Related]
15. HPLC-ECD determination of the enzymatic hydrolysis of [leu]- and [met]enkephalin in rat plasma.
Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
Prog Clin Biol Res; 1990; 328():253-6. PubMed ID: 1968263
[No Abstract] [Full Text] [Related]
16. Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.
Brown DR; Miller RJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):114-9. PubMed ID: 6387084
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
Hussain MA; Rowe SM; Shenvi AB; Aungst BJ
Drug Metab Dispos; 1990; 18(3):288-91. PubMed ID: 2143133
[TBL] [Abstract][Full Text] [Related]
19. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
Bausback HH; Ward PE
Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
[TBL] [Abstract][Full Text] [Related]
20. Transport of the synthetic opioid peptide DADLE ([D-Ala2,D-Leu5]-enkephalin) in neuronal cells.
Ananth S; Thakkar SV; Gnana-Prakasam JP; Martin PM; Ganapathy PS; Smith SB; Ganapathy V
J Pharm Sci; 2012 Jan; 101(1):154-63. PubMed ID: 21905028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
